Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Rocuronium Bromide
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Rocuronium Bromide Injection will be offered as ready-to-administer (RTA) syringe, indicated for inpatients and outpatients as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation.
Product Name : Rocuronium Bromide-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 03, 2023
Lead Product(s) : Rocuronium Bromide
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
